blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0211580

EP0211580 - Renin inhibiting polypeptides and intermediates therefor [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.03.1992
Database last updated on 16.09.2024
Most recent event   Tooltip07.07.2007Change - inventorpublished on 08.08.2007  [2007/32]
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [1987/09]For all designated states
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Inventor(s)01 / Hoover, Dennis Jay
5, Fargo Drive
Ledyard Connecticut / US
[1987/09]
Representative(s)Moore, James William
Pfizer Limited Ramsgate Road Sandwich
Kent CT13 9NJ / GB
[N/P]
Former [1987/09]Moore, James William, Dr.
Pfizer Limited Ramsgate Road
Sandwich Kent CT13 9NJ / GB
Application number, filing date86305722.025.07.1986
[1987/09]
Priority number, dateUS1985076209902.08.1985         Original published format: US 762099
US1985078035326.09.1985         Original published format: US 780353
[1987/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0211580
Date:25.02.1987
Language:EN
[1987/09]
Type: A3 Search report 
No.:EP0211580
Date:09.08.1989
Language:EN
[1989/32]
Search report(s)(Supplementary) European search report - dispatched on:EP21.06.1989
ClassificationIPC:C07K5/00, C07C125/065, A61K37/64, // C07K5/02
[1987/09]
CPC:
C07K5/0227 (EP,US); C07K7/06 (KR); C07K5/06078 (EP,US);
A61K38/00 (EP,US); Y10S530/86 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1987/09]
TitleGerman:Polypeptide Hemmungsstoffe von Renin und deren Zwischenverbindungen[1987/09]
English:Renin inhibiting polypeptides and intermediates therefor[1987/09]
French:Polypeptides inhibiteurs de la rénine et leur intermédiaires[1987/09]
File destroyed:12.06.1999
Examination procedure04.08.1986Examination requested  [1987/09]
19.06.1991Despatch of a communication from the examining division (Time limit: M04)
30.10.1991Application deemed to be withdrawn, date of legal effect  [1992/18]
28.11.1991Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1992/18]
Fees paidRenewal fee
22.06.1988Renewal fee patent year 03
26.06.1989Renewal fee patent year 04
27.06.1990Renewal fee patent year 05
02.07.1991Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US4240975  (AOYAGI TAKAAKI [JP], et al);
 [Y]EP0104964  (SANOFI SA [FR], et al);
 [A]WO8403044  (FERRING AB [SE], et al);
 [E]GB2184730  (SQUIBB & SONS INC)
 [Y]  - JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 94, no. 8, 1972, pages 2855-2859; D. YAMASHIRO et al.: "The use of Nalpha,N-Bis(ter-butyloxycarbonyl)histidine and Nalpha-2-(p-Biphenylyl)isopropyloxycarbonyl-N-tert-butyloxy-carbonylhistidine in the Solid-Phase Synthesis of Histidine-Containing Peptides"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.